reboxetine has been researched along with tolcapone in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (tolcapone) | Trials (tolcapone) | Recent Studies (post-2010) (tolcapone) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 413 | 82 | 132 |
| Protein | Taxonomy | reboxetine (IC50) | tolcapone (IC50) |
|---|---|---|---|
| Transthyretin | Homo sapiens (human) | 3.2 | |
| Catechol O-methyltransferase | Homo sapiens (human) | 0.043 | |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | 0.4661 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.93 | |
| Genome polyprotein | Dengue virus 2 Thailand/16681/84 | 0.64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aonurm-Helm, A; Kaenmaki, M; Mannisto, PT; Tammimaki, A | 1 |
1 other study(ies) available for reboxetine and tolcapone
| Article | Year |
|---|---|
Elimination of extracellular dopamine in the medial prefrontal cortex of conscious mice analysed using selective enzyme and uptake inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Benzophenones; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Dopamine; Female; Homovanillic Acid; Male; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase Inhibitors; Morpholines; Nitrophenols; Pargyline; Prefrontal Cortex; Reboxetine; Synaptosomes; Tolcapone | 2016 |